| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/30/2006 | CN1823604A Seaweed tea and its preparation method |
| 08/30/2006 | CN1272345C Silensed anti-CD 28 antibodies and use thereof |
| 08/30/2006 | CN1272328C Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/30/2006 | CN1272024C Use of dietary additives for preparing medicament for treating malignancies and viral infections and improving immunologic function |
| 08/30/2006 | CN1272010C Powdery respiratory tonic composition |
| 08/29/2006 | US7098373 IL-18 transgenic animal |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098322 Tumor necrosis factor and proteins with amino acid sequences to modulate signal passageways |
| 08/29/2006 | US7098308 Pentapeptide compounds and uses related thereto |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098234 Indole derivatives, process for preparation of the same and use thereof |
| 08/29/2006 | US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 08/29/2006 | US7098218 7,8,9, or 10-sulfamyl, (thio)phosphonyl, sulfonyl, or sulfonamido-naphth[2,1-f]isoquinolin-1,3-diones; drug screening; enzyme inhibitors; anticarcinogenic agents |
| 08/29/2006 | US7098216 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/29/2006 | US7098213 three-ring saturated N-heterocyclic compounds in combination with one or more antiviral or other agents; in immunotherapy |
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7098192 Antisense oligonucleotide modulation of STAT3 expression |
| 08/29/2006 | US7098184 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 08/29/2006 | US7098006 preparation of an antibody chain having a variable domain comprising three complementarity determining regions |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097846 35 kD tumor associated protein antigen: uses and methods of detection |
| 08/29/2006 | US7097845 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 08/29/2006 | US7097844 T helper cell epitopes |
| 08/29/2006 | US7097827 Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2314934C Use of microparticles combined with submicron oil-in-water emulsions |
| 08/29/2006 | CA2240735C Process for production of piperidine derivatives |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/29/2006 | CA2053585C Antibody production in chinese hamster ovary cells |
| 08/24/2006 | WO2006089251A2 SYNERGISTIC EFFECT OF TGF-β BLOCKADE AND IMMUNOGENIC AGENTS ON TUMORS |
| 08/24/2006 | WO2006088833A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088173A1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity |
| 08/24/2006 | WO2006087913A1 Composition for immune activation |
| 08/24/2006 | WO2006087355A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators |
| 08/24/2006 | WO2006086978A2 Use of deuterated n-[2-(5-methoxy-1h-indol-3-yl)-ethyl]acetamides and the pharmaceutically acceptable salts thereof, and medicaments containing said compounds |
| 08/24/2006 | WO2006086888A1 Compositions for treatment of diseases of the nail unit |
| 08/24/2006 | WO2006086822A1 A molecule and chimeric molecules thereof |
| 08/24/2006 | WO2006067635A3 USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT |
| 08/24/2006 | WO2006065746A3 Methods of treating ige-mediated disorders comprising the administration of high concentration anti-ige antibody formulations |
| 08/24/2006 | WO2006007565A8 Cd40 variants skipping exon 5 |
| 08/24/2006 | WO2004069134A8 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 08/24/2006 | US20060189792 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 08/24/2006 | US20060189785 Using biocompatible, low molecular weighty, water solubler polymer; injectable |
| 08/24/2006 | US20060189664 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine |
| 08/24/2006 | US20060189625 Cyclic aminophenyl sulfamate derivative |
| 08/24/2006 | US20060189621 Benzofuran derivative |
| 08/24/2006 | US20060189614 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection |
| 08/24/2006 | US20060189609 1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/24/2006 | US20060189550 Immunostimulatory, Covalently lipidated oligonucleotides |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | US20060189538 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 08/24/2006 | US20060189525 DADD, death activator death domain protein |
| 08/24/2006 | US20060188913 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 08/24/2006 | US20060188636 Papaya puree and the use of the same |
| 08/24/2006 | US20060188585 Nerium oleander extract |
| 08/24/2006 | US20060188577 Element having bioactive substance fixed thereto |
| 08/24/2006 | US20060188534 Dispersions for the formulation of slightly or poorly soluble agents |
| 08/24/2006 | US20060188521 Disrupting sex steroid signal to thymus: bone marrow or hematopoietic cells |
| 08/24/2006 | US20060188502 Nucleic acid encoding a chimeric, humanized or CDR-grafted antibody that binds and inhibits the activity of human IL-6 |
| 08/24/2006 | US20060188485 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | CA2598090A1 Synergistic effect of tgf-beta blockade and immunogenic agents on tumors |
| 08/24/2006 | CA2597896A1 1h-imidazole derivatives as cannabinoid cb2 receptor modulators |
| 08/24/2006 | CA2597795A1 A molecule and chimeric molecules thereof |
| 08/24/2006 | CA2596680A1 Composition for immunostimulation |
| 08/24/2006 | CA2596509A1 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 08/24/2006 | CA2595620A1 Compositions for treatment of diseases of the nail unit |
| 08/24/2006 | CA2594490A1 Methods of treating skin disorders using an il-31ra antagonist |
| 08/24/2006 | CA2572151A1 Oligonucleotides comprising a non-phosphate backbone linkage |
| 08/23/2006 | EP1693459A1 Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus |
| 08/23/2006 | EP1693448A1 Double specific antibodies substituting for functional protein |
| 08/23/2006 | EP1693384A2 Functional immunoglobulins against human serum albumin, fragments thereof, library thereof and methods of production thereof |
| 08/23/2006 | EP1693382A2 Melanocortin 1 receptor selective compounds |
| 08/23/2006 | EP1693373A1 Enantiomerically pure beta-D-(-)-dioxolane-nucleosides |
| 08/23/2006 | EP1693367A1 Piperidine compound and method for producing same |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1693063A1 Antiallergic agent containing ground lotus and/or extract thereof together with lactic acid bacterium |
| 08/23/2006 | EP1692276A2 Method of inducing memory b cell development and terminal differentiation |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1691837A2 Ip-10 antibodies and their uses |
| 08/23/2006 | EP1691814A2 Anti-inflammatory agents |
| 08/23/2006 | EP1507794B1 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1369489B1 Flavonoid compound and process for producing the same |
| 08/23/2006 | EP1339294B1 Nutritional composition for an immune condition |
| 08/23/2006 | EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 08/23/2006 | EP1290939B1 Caspase 1 gene transfer animal |
| 08/23/2006 | EP1237537B1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1212058B1 Topical treatment for prevention of ocular infections |
| 08/23/2006 | EP1198232B1 Urea substituted imidazoquinolines |
| 08/23/2006 | EP1178824B1 Staphylococcus aureus antigen-containing whole cell vaccine |
| 08/23/2006 | EP1146870B1 Antioxidant compositions for companion animals |